Revvity (RVTY) Share-based Compensation Growth (3y) (2012 - 2026)
Revvity (RVTY) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -20.63% |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn | -4.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -4.14% |
| Dec 28, 2025 | -28.40% |
| Mar 30, 2025 | -18.80% |
| Sep 29, 2024 | 34.23% |
| Jun 30, 2024 | 13.47% |
| Mar 31, 2024 | 31.37% |
| Dec 31, 2023 | 0.22% |
| Oct 1, 2023 | 124.41% |
| Jul 2, 2023 | 102.86% |
| Apr 2, 2023 | 48.03% |
| Jan 1, 2023 | 75.76% |
| Apr 3, 2022 | 119.19% |
| Oct 3, 2021 | -26.84% |
| Jul 4, 2021 | 1.86% |
| Apr 4, 2021 | -1.11% |
| Jan 3, 2021 | -8.27% |
| Oct 4, 2020 | -40.13% |
| Jul 5, 2020 | -37.97% |
| Apr 5, 2020 | -14.77% |
| Dec 29, 2019 | 11.09% |